Norio Asou Selected Research

Norio Asou Research Topics

Disease

22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2003
22	Leukemia 02/2021 - 02/2002
13	Acute Promyelocytic Leukemia 12/2020 - 08/2005
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2017
9	Neoplasms (Cancer) 01/2020 - 09/2003
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2014
4	Thrombocytopenia (Thrombopenia) 01/2022 - 11/2005
4	Febrile Neutropenia 01/2022 - 05/2010
4	Hemorrhage 12/2020 - 11/2005
4	Infections 11/2017 - 07/2003
3	Aplastic Anemia (Anemia, Hypoplastic) 09/2018 - 11/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2008 - 05/2005
2	Pneumonia (Pneumonitis) 08/2021 - 03/2007
2	Diarrhea 01/2020 - 09/2003
2	Disease Progression 12/2019 - 01/2017
2	Lymphoma (Lymphomas) 01/2019 - 03/2016
2	Genetic Translocation (Chromosomal Translocation) 01/2018 - 05/2007
2	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 05/2010
2	Neutropenia 05/2010 - 03/2009
1	Exanthema (Rash) 03/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022
1	Constipation 01/2022
1	Leukocytosis (Pleocytosis) 12/2020
1	Sepsis (Septicemia) 04/2020
1	Leukopenia 01/2020
1	Thymoma (Thymic Carcinoma) 01/2020
1	Edema (Dropsy) 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Philadelphia Chromosome 12/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2019
1	Second Primary Neoplasms (Neoplasms, Second) 05/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2016
1	Fatigue 03/2016
1	Hemolytic Anemia 02/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2016
1	Disseminated Intravascular Coagulation 01/2014
1	Primary Myelofibrosis (Myelosclerosis) 01/2014
1	Pathologic Complete Response 02/2011

Drug/Important Bio-Agent (IBA)

10	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 04/2006
7	Tyrosine Kinase InhibitorsIBA 12/2019 - 01/2017
6	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2021 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2002
3	Pharmaceutical PreparationsIBA 03/2022 - 09/2003
3	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2014
3	Imatinib Mesylate (Gleevec)FDA Link 12/2020 - 09/2010
3	nilotinib FDA Link 09/2018 - 02/2018
2	venetoclaxIBA 01/2022 - 08/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 05/2005
2	tamibaroteneIBA 01/2019 - 11/2014
2	Dasatinib (BMS 354825)FDA Link 09/2018 - 05/2018
2	polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA 09/2018 - 11/2005
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 06/2003
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018 - 10/2006
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 05/2007
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2011 - 03/2010
2	Micafungin (FK463)FDA Link 05/2010 - 03/2009
2	EchinocandinsIBA 05/2010 - 03/2009
2	AclarubicinIBA 05/2010 - 01/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2010 - 01/2009
1	Bendamustine Hydrochloride FDA Link 03/2022
1	Keratins (Keratin)IBA 02/2021
1	AnticoagulantsIBA 12/2020
1	amrubicinIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	tegafur-gimeracil-oteracilIBA 01/2020
1	titanium silicide (TS-1)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 02/2018
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2018
1	ProcalcitoninIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	C-Reactive ProteinIBA 11/2017
1	CohesinsIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 03/2016
1	Immunologic Factors (Immunomodulators)IBA 03/2016
1	Inosine Triphosphate (ITP)IBA 02/2016
1	ChromatinIBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 06/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	CD56 AntigenIBA 01/2014
1	Serine (L-Serine)FDA Link 01/2013
1	AnthracyclinesIBA 11/2012
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2011

Therapy/Procedure

22	Therapeutics 02/2021 - 11/2005
16	Drug Therapy (Chemotherapy) 01/2022 - 07/2003
6	Hematopoietic Stem Cell Transplantation 04/2020 - 03/2009
4	Remission Induction 12/2020 - 03/2007
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2016 - 09/2005
2	Radiotherapy 01/2020 - 01/2020
2	Induction Chemotherapy 03/2010 - 07/2003
1	Endoscopes 01/2020
1	Transplantation 09/2016
1	Consolidation Chemotherapy 02/2011